Index of artpub/2023/303870/

Blanco, Remei
Pembrolizumab as first-line treatment for advanced NSCLC in older adults : A phase II clinical trial evaluating geriatric and quality-of-life outcomes
2023
https://ddd.uab.cat/record/303870